FDA approves first nasal spray flu vaccine for use at home
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health ...
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
4d
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...
The U.S. Food and Drug Administration does not set limits on PFAS levels in food. But, responding to rising public ...
A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback